A Phase 1 / 2 clinical trial evaluating safety and immunogenicity of a varicella zoster glycoprotein E subunit vaccine candidate in young and older adults
The Journal of Infectious Diseases, 08/09/2012
Leroux–Roels I et al. – In this study, HZ/su adjuvanted subunit vaccine was well–tolerated and more immunogenic than a live attenuated VZV vaccine.



